Table 2.
Variables | Frequency | % |
---|---|---|
N = 705 | ||
Age group | ||
1 to 9 | 42 | 6.0 |
10 to 19 | 43 | 6.1 |
20 to 24 | 22 | 3.1 |
25 to 30 | 31 | 4.4 |
31 to 40 | 127 | 18.0 |
41 to 50 | 240 | 34.0 |
51 and above | 200 | 28.4 |
Age description | ||
Child | 42 | 6.0 |
Adolescent | 43 | 6.1 |
Youth | 22 | 3.1 |
Older adults | 598 | 84.8 |
Gender | ||
Male | 317 | 45.0 |
Female | 388 | 55.0 |
Education | ||
None | 4 | 0.6 |
Preschool | 16 | 2.3 |
Primary | 133 | 18.9 |
Secondary | 156 | 22.1 |
Postsecondary | 88 | 12.5 |
Not documented | 308 | 43.6 |
Marital status | ||
Child | 63 | 8.9 |
Single | 163 | 23.1 |
Married | 358 | 50.8 |
Separated/divorced | 40 | 5.7 |
Widowed | 49 | 7.0 |
Not documented | 32 | 4.5 |
Age at HIV diagnosis | ||
1 to 9 | 74 | 10.4 |
10 to 19 | 18 | 2.5 |
20 to 29 | 57 | 8.1 |
30 to 39 | 133 | 18.9 |
40 to 49 | 71 | 10.1 |
50 and above | 28 | 4.0 |
Not documented | 324 | 46.0 |
Years positive | ||
0 to 5 | 58 | 8.2 |
6 to 10 | 140 | 19.9 |
11 and above | 194 | 27.5 |
Not documented | 313 | 44.4 |
Baseline WHO stage | ||
Stage 1 | 244 | 34.6 |
Stage 2 | 95 | 13.5 |
Stage 3 | 155 | 22.0 |
Stage 4 | 59 | 8.4 |
Not documented | 152 | 21.5 |
Baseline viral load | ||
Nondetectable | 263 | 37.3 |
20 to 999 | 281 | 39.9 |
1000 and above | 161 | 22.8 |
TB history | ||
Yes | 106 | 15.0 |
No | 599 | 85.0 |
OI history | ||
Yes | 555 | 78.7 |
No | 150 | 21.3 |
PCP | ||
Yes | 4 | 0.6 |
No | 701 | 99.4 |
Cryptococcal disease | ||
Yes | 4 | 0.6 |
No | 701 | 99.4 |
Oral candidiasis | ||
Yes | 32 | 4.5 |
No | 673 | 95.5 |
Kaposi's sarcoma | ||
Yes | 3 | 0.4 |
No | 702 | 99.6 |
Other cancers | ||
Yes | 15 | 2.1 |
No | 690 | 97.9 |
Hypertension | ||
Yes | 92 | 13.0 |
No | 613 | 87.0 |
Diabetes | ||
Yes | 23 | 3.3 |
No | 682 | 96.7 |
Renal disease | ||
Yes | 22 | 3.1 |
No | 683 | 96.9 |
IPT status | ||
Completed | 401 | 56.9 |
Deferred | 137 | 19.4 |
Start | 21 | 3.0 |
Continuing | 35 | 5.0 |
Declined | 10 | 1.4 |
Defaulted | 4 | 0.6 |
Not documented | 97 | 13.7 |
Start VL at PLLV | ||
20 to 199 | 532 | 75.5 |
200 to 499 | 113 | 16.0 |
599 to 999 | 60 | 8.5 |
Start regimen | ||
2NRTI+1PI/r | 133 | 18.9 |
2NRTI+1NNRTI | 545 | 77.3 |
2NRTI+1INSTI | 27 | 3.8 |
Switched regimen at PLLV | ||
Yes | 329 | 46.7 |
No | 376 | 53.3 |
Baseline CD4 | ||
<500 | 103 | 14.6 |
≥500 | 28 | 4.0 |
Not documented | 574 | 81.4 |